In order to establish the efficacy of resveratrol against IGF-1 induced colon cancer growth, we utilized HT-29 and SW480 (IGF-1R constitutively active) human colon cancer cell lines and treated them with/without IGF-1 and/or resveratrol. Here, IGF1 is linked to colonic neoplasm.